Biotech Values

[rkrw]

My first read of the Astellas PR was that part of the appeal to their bid was keeping the company in place and not just gutting it for the royalties.

<<Astellas' scale and financial strength will help OSI realize the value of its current product pipeline, as well as continue the necessary funding of its discovery engine. Adding Astellas' strong business operations and experience in the development and sales of new products will enable the combined company to accelerate their development and ensure their successful commercialization. Astellas has great respect for the OSI organization and expects to integrate the strengths of OSI's business and employees into its operations as it has in the past with similar strategic acquisitions.>>